190 related articles for article (PubMed ID: 22463081)
1. Estrogen receptor α and β in esophageal squamous cell carcinoma.
Zuguchi M; Miki Y; Onodera Y; Fujishima F; Takeyama D; Okamoto H; Miyata G; Sato A; Satomi S; Sasano H
Cancer Sci; 2012 Jul; 103(7):1348-55. PubMed ID: 22463081
[TBL] [Abstract][Full Text] [Related]
2. Expression of estrogen receptor α and β in esophageal squamous cell carcinoma.
Dong J; Jiang SW; Niu Y; Chen L; Liu S; Ma T; Chen X; Xu L; Su Z; Chen H
Oncol Rep; 2013 Dec; 30(6):2771-6. PubMed ID: 24101172
[TBL] [Abstract][Full Text] [Related]
3. Characterization of serum estradiol level and tissue estrogen receptor immunostaining with clinical response and reproductive factor changes in Chinese female patients with esophageal squamous cell carcinoma.
Zhang D; Ku J; Liu R; Wu H; Liang G; Wei Y; Chen P; Zhao X; Liu S; Li Y; Yao J; Song X; Wang L
Biomed Pharmacother; 2017 Sep; 93():879-884. PubMed ID: 28724213
[TBL] [Abstract][Full Text] [Related]
4. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
[TBL] [Abstract][Full Text] [Related]
5. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
[TBL] [Abstract][Full Text] [Related]
6. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.
Teng J; Wang ZY; Jarrard DF; Bjorling DE
Endocr Relat Cancer; 2008 Mar; 15(1):351-64. PubMed ID: 18310301
[TBL] [Abstract][Full Text] [Related]
7. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
[TBL] [Abstract][Full Text] [Related]
8. Selective oestrogen receptor antagonists inhibit oesophageal cancer cell proliferation in vitro.
Al-Khyatt W; Tufarelli C; Khan R; Iftikhar SY
BMC Cancer; 2018 Feb; 18(1):121. PubMed ID: 29390981
[TBL] [Abstract][Full Text] [Related]
9. Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus.
Nozoe T; Oyama T; Takenoyama M; Hanagiri T; Sugio K; Yasumoto K
Clin Cancer Res; 2007 Jul; 13(14):4046-50. PubMed ID: 17634528
[TBL] [Abstract][Full Text] [Related]
10. Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.
Yu CP; Ho JY; Huang YT; Cha TL; Sun GH; Yu DS; Chang FW; Chen SP; Hsu RJ
PLoS One; 2013; 8(2):e56667. PubMed ID: 23460808
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor α mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor β.
Galea GL; Meakin LB; Sugiyama T; Zebda N; Sunters A; Taipaleenmaki H; Stein GS; van Wijnen AJ; Lanyon LE; Price JS
J Biol Chem; 2013 Mar; 288(13):9035-48. PubMed ID: 23362266
[TBL] [Abstract][Full Text] [Related]
12. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
13. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen.
Wu X; Subramaniam M; Grygo SB; Sun Z; Negron V; Lingle WL; Goetz MP; Ingle JN; Spelsberg TC; Hawse JR
Breast Cancer Res; 2011 Mar; 13(2):R27. PubMed ID: 21392396
[TBL] [Abstract][Full Text] [Related]
15. Regulation of estrogen receptor (ER) isoform messenger RNA expression by different ER ligands in female rat pituitary.
Tena-Sempere M; Navarro VM; Mayen A; Bellido C; Sánchez-Criado JE
Biol Reprod; 2004 Mar; 70(3):671-8. PubMed ID: 14613904
[TBL] [Abstract][Full Text] [Related]
16. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
[TBL] [Abstract][Full Text] [Related]
17. Expression of Estrogen Receptors in OSCC in Relation to Histopathological Grade.
Doll C; Arsenic R; Lage H; Jöhrens K; Hartwig S; Nelson K; Raguse JD
Anticancer Res; 2015 Nov; 35(11):5867-72. PubMed ID: 26504009
[TBL] [Abstract][Full Text] [Related]
18. Endogenous estrogen receptor beta is transcriptionally active in primary ovarian cells from estrogen receptor knockout mice.
Mueller SO; Katzenellenbogen JA; Korach KS
Steroids; 2004 Sep; 69(10):681-6. PubMed ID: 15465114
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
